Inhibitory effect of lotus seedpod oligomeric procyanidins on advanced glycation end product formation in a lactose-lysine model system
Reprint PDF

Keywords

advanced glycation end products (AGEs)
lactose
Lotus seedpod oligomeric procyanidins (LSOPC)
lysine
Maillard reaction

How to Cite

1.
Wu Q, Li S-Y, Yang T, Xiao J, Chu Q-M, Li T, Xie B-J, Sun Z-D. Inhibitory effect of lotus seedpod oligomeric procyanidins on advanced glycation end product formation in a lactose-lysine model system. Electron. J. Biotechnol. [Internet]. 2015 Mar. 9 [cited 2024 Sep. 19];18(2). Available from: https://preprints.pucv.cl/index.php/ejbiotechnology/article/view/2014.10.005

Abstract

Background: Industrial food processing induces protein glycation modifications and toxic advanced glycation end products (AGEs) which affect human health. Therefore, it is of interest to monitor AGEs in food processing. The present study was carried out to investigate the influence of lotus seedpod oligomeric procyanidin (LSOPC) concentrations, solution pH value and metal ions on AGE formation by heat treatment of lactose-lysine model solutions. Nε-(carboxymethyl) lysine (CML), as one of the common AGEs was also determined by HPLC-MS/MS in this experiment.

Results: The results showed that LSOPC can inhibit the formation of AGEs effectively at higher concentrations, lower temperature, and it can reverse the promotion function of metal ions because of its high inhibition activity. Also, LSOPC can inhibit CML formation in the Maillard reaction as well.

Conclusion: These results indicated that LSOPC could be used as functional food ingredients to inhibit AGE formation.
Reprint PDF

Upon acceptance of an article by the journal, authors will be asked to transfer the copyright to Electronic Journal of Biotechnology, which is committed to maintain the electronic access to the journal and to administer a policy of fair control and ensure the widest possible dissemination of the information. The author can use the article for academic purposes, stating clearly the following: "Published in Electronic Journal of Biotechnology at DOI:10.2225/volXX-issueX-fulltext-XX".

The Copyright Transfer Agreement must be submitted as a signed scanned copy to biotec@ucv.cl. All authors must send a copy of this document.